All In MedTech

Device Trial Radar · NCT07267143

18-month Clinical Performance of Stand Alone and Nanohybrid Supported Injectable Composite Veneers

Beyond the Mold : 18-month Clinical Performance of Stand-alone and Nanohybrid-supported Injectable Composite veneers-a Randomized Controlled Trial

Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

45

Actual

Start

Jan 1, 2024

Primary completion

Jun 1, 2026

Study completion Jun 1, 2026

Sponsor

Lead sponsor
Tolunay AytasAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 5, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (investigator)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 35 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a double blinded, randomized clinical study that evaluated the performance of a high filled injectable resin composite in polydiastema . The polydiastema disorders will be restored with high filled injectable resin composite (G'aenial Injectable Universal ) or anterior composite resin (G-aenial A'chord ). Restorations will be evaluated after 12 months according to FDI criteria and the data will be analyzed.

Conditions

  • Polydiastema Disorder

Interventions

  • Nanohybrid Composite (G-ænial A'Chord, GC Corp., Tokyo, Japan)Device

    Conventional nanohybrid resin composite (G-ænial A'Chord, GC Corp., Tokyo, Japan) was used for direct anterior veneer restorations. The material was applied using a free-hand layering technique following digital smile design and wax-up. A transparent silicone index (Exaclear, GC Corp.) was used for shape guidance when necessary. The enamel surfaces were etched with 37% phosphoric acid and bonded with a universal adhesive (G2 Bond, GC Corp.) before composite application. This intervention represents the standard clinical technique for direct composite veneers and serves as the active comparator group.

  • Highly Filled Injectable Composite (G-ænial Universal Injectable, GC Corp., Tokyo, Japan)Device

    Highly filled flowable injectable composite resin (G-ænial Universal Injectable, GC Corp., Tokyo, Japan) was used either as a sole restorative material or in combination with a nanohybrid composite for direct anterior veneers. For the injection process, a transparent PVS index (Exaclear, GC Corp.) was fabricated from a wax-up model and used to guide the placement of the material. In the combined technique, a 1-mm palatal layer of nanohybrid composite was placed first, followed by the injection of the flowable composite. The procedure aimed to improve adaptation, minimize voids, and optimize esthetic results compared to the conventional layering method.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Functional properties scoreTime frame: 1 year
  2. Esthetic properties scoreTime frame: 1 year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hacettepe University Faculty of Dentistry

    Ankara, Turkey (Türkiye)

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.